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Hypertension leads all other risk factors in the reduction of dis-
ability-adjusted life years.1 Despite its commonality and morbidity, 
hypertension screening and control continues to be suboptimal.2 
Home cuff-based blood pressure (BP) monitors are cumbersome and 
uncomfortable, which we think limits their potential for widespread 
adoption in hypertension screening and monitoring of BP control 
among those known to have the condition. Non-invasive BP mon-
itors with the convenience of a smartwatch might overcome such 
barriers and aid hypertension detection and control efforts. One 
potential technology utilizes pulse transit time (PTT) to measure 
BP, and users report this method to be more convenient than cuff-
based methods.3 PTT represents the time it takes for a pulse wave to 
travel from the heart to a peripheral point and is typically measured 
using the R-wave on electrocardiogram and a finger or wrist pleth-
ysmography sensor. PTT shortens when BP increases as described 
by the Moens–Korteweg Equation.4 In short, the equation describes 
that arteries become stiffer when they are distended at a higher BP, 
and a pulse wave travels faster through a rigid tube than through an 
elastic tube. PTT devices must be calibrated at first use against a 
standard device to accommodate for differences in arterial elasticity. 
As with all new technologies, it is essential that PTT-based devices 
undergo rigorous assessment in order to ensure the accuracy of the 
measurements and inform their use in clinical practice. Conventional 
BP monitor validation protocols compare a static series of measure-
ments from an investigational and reference device, and a PTT de-
vice that simply repeats back the calibration BP will meet accuracy 
criteria since the calibration BP and the reference device BP are the 
same.5 More appropriate validation protocols for PTT devices in-
clude validation measurements after changes in BP and after hours 
or days since calibration.6,7 Clinical studies of PTT devices might in-
clude an extended comparison against a reference device to take 
advantage of naturally occurring variations in BP throughout a 24-
hour period. Specifically, BP is known to dip at nighttime in some 
people,8 and a PTT-based BP device should detect these dips at the 
same frequency as the reference device. Rigorous assessment of 
PTT devices would compare throughout a day against an automated 
24-hour cuff-based monitoring device.
In this issue of the Journal of Clinical Hypertension, Nyvad 
et al9 report a clinical comparison between 24-hour BP measure-
ments obtained with 1) A PTT-based cuff-less BP measurement de-
vice running two different variations of software (SOMNOtouch, 
SOMNOmedics, Randersacker, Germany) and, 2) A validated 
cuff-based automated oscillometric BP measurement device 
(SPACELABS 90217, Snoqualmie, WA, USA).10 The researchers are 
to be applauded for a thoughtful, rigorous assessment that included 
51 adult participants with a wide spread of baseline systolic BPs. 
Correlation between hypertension-level measurements from the 
SOMNOtouch and reference devices was poor, especially over-
night. The reference device observed a nighttime dip in systolic and 
diastolic measurements in 45% and 73% of participants, respec-
tively. The two software versions of SOMNOtouch only identified 
systolic nighttime dipping in 2% and 22% and diastolic dipping in 
16% and 0%. Specifically, the reference device recorded mean 
daytime BP that was higher (142 ± 20/83 ± 11 mm Hg) than mean 
nighttime BP (129 ± 20/72 ± 10 mm Hg). In contrast, the observed 
SOMNOtouch BP was similar between daytime (148 ± 25/85 ± 13 
and 147 ± 20/84 ± 14 mm Hg for each software version) and night-
time (146 ± 26/84 ± 13 and 141 ± 28/81 ± 14 mm Hg).
The findings from the present manuscript expand the amassing 
documentation of poor performance of PTT-based BP monitors.11-13 
Obtaining validation measurements immediately after calibration 
at the same BP falsely establishes accuracy and precision of PTT 
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devices14 as demonstrated by the results from Nyvad's work.9 As 
noted by the authors, the fundamental limitation of PTT devices is 
that they become inaccurate when the relationship between PTT 
and BP changes in an individual. The mathematical PTT-based esti-
mation of BP assumes that the heart and arteries behave like a con-
stant pump and inert rubber tubes, ignoring the important influence 
of factors such as activity level and sympathetic tone. Physiological 
studies have demonstrated that intraindividual changes in cardiac 
contractility and vascular smooth muscle tone make the PTT method 
a poor BP estimation model.15 The particularly poor agreement be-
tween SOMNOtouch and cuff-based BP measurements at night that 
Nyvad et al found seems to underscore this point, considering the 
SOMNOtouch was calibrated during the day.
In conclusion, the study by Nyvad et al provides important in-
formation on the limited clinical value of PTT-based BP monitors. 
The inherent physiological confounding of PTT-based BP estimation 
makes it difficult to envision that this type of measurement will have 
clinical utility. Other innovative cuff-less BP measurement methods 
that are more closely related to BP in a local blood vessel are currently 
being studied16 and will hopefully eventually be found to be accurate 
and precise. We think that any future validation studies claiming that 
PTT devices are accurate should use protocols that were specifically 
developed for cuff-less BP measurement devices,6,7 in addition to a 
meaningful clinical comparison study. Nyvad et al’s effort highlights 
that a crucial step toward achieving confidence in the clinical use 
of cuff-less BP monitoring is that the marketing and sale of devices 
does not precede assurance of clinical accuracy and performance.
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